| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V59051 | RXFP1 receptor agonist-4 | 2941376-76-5 | RXFP1 receptor agonist-4 (Example 268) is an RXFP1 receptor agonist. |
|
V61656 | RXFP1 receptor agonist-5 | 2941385-36-8 | RXFP1 receptor agonist-5 (Example 98) is an RXFP1 receptor agonist. |
|
V57114 | RXFP1 receptor agonist-6 | 2941346-85-4 | RXFP1 receptor agonist-6 (Example 7) is an RXFP1 receptor agonist. |
|
V58080 | RXFP1 receptor agonist-7 | 2941484-13-3 | RXFP1 receptor agonist-7 (Example 2) is an RXFP1 receptor agonist. |
|
V62688 | RXFP1 receptor agonist-8 | 2941271-76-5 | RXFP1 receptor agonist-8 (Example 2) is an RXFP1 receptor agonist. |
|
V62713 | RXFP2 agonist 2 | 2971704-85-3 | RXFP2 agonist 2 is a selective, orally bioactive allosteric agonist of RXFP2 with EC50 of 0.38 µM. |
|
V58883 | RXFP2agonist 1 | 2971704-58-0 | RXFP2 agonist 1 (Compound 1715) is a potent RXFP2 agonist/activator with EC50 of 0.06 µM. |
|
V59906 | RXFP3/4 agonist 1 | 2351104-40-8 | RXFP3/4 agonist 1 is a relaxin family peptide 3/4 receptor (RXFP3/4) inhibitor (antagonist) with EC50s of 82 and 2 nM, respectively. |
|
V64534 | RXFP3/4 agonist 2 | 2752378-78-0 | RXFP3/4 agonist 2 is a potent, non-peptide dual RXFP3/4 agonist (EC50=3.1 and 2.7 nM). |
|
V58706 | RXFP3agonist 1 | 2752378-24-6 | RXFP3 agonist 1 is a non-peptide RXFP3 agonist (EC50=6937 nM). |
|
V57350 | RyRs activator 4 | 2987900-56-9 | RyRs activator 4 is an insect ryanodine receptor agonist/activator. |
|
V61428 | S-(+)-Arundic Acid ((S)ONO-2506; (S)-2-Propyloctanoic acid) | 807363-10-6 | S-(+)-Arundic Acid ((S)ONO-2506) is the S-enantiomer of Arundic Acid. |
|
V61805 | S-(-)-Warfarin-d5 ((S)-Warfarin-d5) | 791013-22-4 | S-(-)-Warfarin-d5 is the deuterated form of S-(-)-Warfarin. |
|
V59854 | S-Octylglutathione | 24435-27-6 | S-Octylglutathione is a competitive inhibitor of glutathione sulfur transsulfurase (GST). |
|
V58137 | S07-1066 | 876625-29-5 | S07-1066 is an inhibitor (blocker/antagonist) of aldehyde-keto reductase AKR1C3 and can synergistically enhance doxorubicin (DOX) cytotoxic effect. |
|
V62479 | S62798 | 2107353-05-7 | S62798 is a potent and selective thrombin-activated fibrin inhibitor (TAFIa) with IC50 of 6 mM. |
|
V64175 | Salcaprozate sodium (SNAC) | 203787-91-1 | Salcaprozate sodium (SNAC) is an oral absorption enhancer with potential as a delivery agent for oral forms of heparin and insulin. |
|
V60884 | Salicylamide-O-acetic acid (2-(2-carbamoylphenoxy)acetic acid) | 25395-22-6 | Salicylamide-O-acetic acid is theophylline solubilizer. |
|
V59037 | Salpyran | 2719737-44-5 | Salpyran is a copper(II) selective chelator with research potential. |
|
V58782 | Sarbronin M | 1367624-30-3 | Scabronine M is a novel inhibitor of NGF-induced neurite outgrowth of PC12 cells. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
